• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Provincial screening rates for chronic diseases of lifestyle, cancers and HIV in a health-insured population.参保人群中生活方式慢性病、癌症和艾滋病的省级筛查率。
S Afr Med J. 2013 May;103(5):309-12. doi: 10.7196/samj.6686.
2
Screening for chronic diseases in South Africa.南非的慢性病筛查。
S Afr Med J. 2013 May;103(5):289. doi: 10.7196/samj.6934.
3
Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa.南非医保人群中,生活方式相关慢病、癌症和 HIV 筛查指南依从性的预测因素。
Glob Health Action. 2014 Mar 14;7:23807. doi: 10.3402/gha.v7.23807. eCollection 2014.
4
Cancer diagnostic service use in people living with HIV in South Africa: A cross-sectional study.南非艾滋病毒感染者的癌症诊断服务使用情况:一项横断面研究。
PLoS One. 2024 Jun 13;19(6):e0291897. doi: 10.1371/journal.pone.0291897. eCollection 2024.
5
The South African HIV epidemic, reflected by nine provincial epidemics, 1990-1996.1990 - 1996年期间,南非的艾滋病流行情况通过九个省级疫情得以体现。
S Afr Med J. 1998 Oct;88(10):1320-5.
6
The geographic distribution of priority population groups for the elimination of mother-to-child transmission of HIV in South Africa.南非消除艾滋病毒母婴传播重点人群的地理分布。
PLoS One. 2020 Apr 8;15(4):e0231228. doi: 10.1371/journal.pone.0231228. eCollection 2020.
7
Diabetes in the public healthcare sector of four South African provinces: A comparative analysis.南非四个省份公共医疗部门中的糖尿病:一项比较分析。
S Afr Med J. 2022 Nov 1;112(11):855-859. doi: 10.7196/SAMJ.2022.v112i11.16546.
8
Provider performance in treating poor patients--factors influencing prescribing practices in lao PDR: a cross-sectional study.老挝人民民主共和国中影响处方实践的因素:一项横断面研究——治疗贫困患者方面的提供者表现。
BMC Health Serv Res. 2011 Jan 6;11:3. doi: 10.1186/1472-6963-11-3.
9
Provincial mortality in South Africa, 2000--priority-setting for now and a benchmark for the future.2000年南非各省的死亡率——当前的优先事项设定及未来的基准
S Afr Med J. 2005 Jul;95(7):496-503.
10
HIV primary care by the infectious disease physician in the United States - extending the continuum of care.美国传染病医生提供的HIV初级护理——扩展护理连续体
AIDS Care. 2018 May;30(5):569-577. doi: 10.1080/09540121.2017.1385720. Epub 2017 Oct 9.

引用本文的文献

1
Insights into Pneumocystis jirovecii pneumonia in South Africa (2018-2022).南非肺孢子菌肺炎的研究洞察(2018 - 2022年)
Med Mycol. 2025 Jan 25;63(2). doi: 10.1093/mmy/myaf001.
2
Use of Machine Learning and Statistical Algorithms to Predict Hospital Length of Stay Following Colorectal Cancer Resection: A South African Pilot Study.使用机器学习和统计算法预测结直肠癌切除术后的住院时间:一项南非的试点研究。
Front Oncol. 2021 Oct 1;11:644045. doi: 10.3389/fonc.2021.644045. eCollection 2021.
3
Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa.南非在实现2020年艾滋病毒诊断和抗逆转录病毒治疗目标方面取得的进展。
South Afr J HIV Med. 2017 Jul 27;18(1):694. doi: 10.4102/sajhivmed.v18i1.694. eCollection 2017.
4
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.非洲宫颈癌的预防与治疗研究:基于公共卫生视角的系统评价
BMC Womens Health. 2016 Jun 4;16:29. doi: 10.1186/s12905-016-0306-6.
5
Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey.南非的医疗保健可及性维度与宫颈癌筛查:世界卫生调查分析
BMC Public Health. 2015 Apr 15;15:382. doi: 10.1186/s12889-015-1686-5.
6
Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa.南非医保人群中,生活方式相关慢病、癌症和 HIV 筛查指南依从性的预测因素。
Glob Health Action. 2014 Mar 14;7:23807. doi: 10.3402/gha.v7.23807. eCollection 2014.

本文引用的文献

1
Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study.意大利乳腺癌和宫颈癌筛查普及率的社会经济差异:一项横断面研究。
BMC Public Health. 2012 Feb 3;12:99. doi: 10.1186/1471-2458-12-99.
2
Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.与宫颈癌筛查及异常结果随访相关的社会人口学因素。
Can Fam Physician. 2012 Jan;58(1):e22-31.
3
Health insurance and household income associated with mammography utilization among American women, 2000 - 2008.2000-2008 年美国女性中医疗保险和家庭收入与乳房 X 光摄影利用的关系。
Chin Med J (Engl). 2011 Oct;124(20):3320-6.
4
Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries.乳腺钼靶筛查:德国及其他欧洲国家的证据、历史与当前实践
Breast Care (Basel). 2011;6(2):104-109. doi: 10.1159/000327493. Epub 2011 Apr 29.
5
Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA.40岁及以上且曾听说过前列腺特异性抗原(PSA)检测的男性中PSA筛查的预测因素。
Korean J Urol. 2010 Jun;51(6):391-7. doi: 10.4111/kju.2010.51.6.391. Epub 2010 Jun 21.
6
Health behaviors of employed and insured adults in the United States, 2004-2005.美国就业和参保成年人的健康行为,2004-2005 年。
Am J Health Promot. 2010 May-Jun;24(5):315-23. doi: 10.4278/ajhp.080603-QUAN-77.
7
Systematic review: enhancing the use and quality of colorectal cancer screening.系统评价:提高结直肠癌筛查的使用和质量。
Ann Intern Med. 2010 May 18;152(10):668-76. doi: 10.7326/0003-4819-152-10-201005180-00239. Epub 2010 Apr 13.
8
Factors related to use of prostate cancer screening: the Alberta Tomorrow Project.与前列腺癌筛查使用相关的因素:艾伯塔省明日项目
Open Med. 2007 Apr 14;1(1):e3-e12.
9
Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).美国 25-64 岁女性宫颈癌筛查指南的依从性:来自 2005 年健康信息国家趋势调查(HINTS)的数据。
J Womens Health (Larchmt). 2009 Nov;18(11):1759-68. doi: 10.1089/jwh.2009.1430.
10
The health and health system of South Africa: historical roots of current public health challenges.南非的健康与卫生系统:当前公共卫生挑战的历史根源
Lancet. 2009 Sep 5;374(9692):817-34. doi: 10.1016/S0140-6736(09)60951-X. Epub 2009 Aug 24.

参保人群中生活方式慢性病、癌症和艾滋病的省级筛查率。

Provincial screening rates for chronic diseases of lifestyle, cancers and HIV in a health-insured population.

机构信息

School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

出版信息

S Afr Med J. 2013 May;103(5):309-12. doi: 10.7196/samj.6686.

DOI:10.7196/samj.6686
PMID:23971120
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3752603/
Abstract

BACKGROUND

Screening for asymptomatic diseases can reduce the burden of morbidity and mortality in all population groups. There is widespread geographical variation in the quality of care. Few data are available on national screening rates in South Africa and how these vary across the provinces.

OBJECTIVE

To examine screening rates for chronic diseases of lifestyle (CDL), HIV and cancer in a privately insured population for a single insurer across all nine provinces in South Africa, and to determine whether or not there are any differences between the provinces.

METHOD

Screening rates were calculated as the proportion of eligible members who had received screening tests during 2011 in each province. Mean screening rates were compared between Gauteng and the other eight provinces.

RESULTS

Nationwide screening rates were 20.5% for CDL, 8.2% for HIV and 31.9% for cancer. Despite similar insurance coverage, screening rates ranged from 0.3% to 0.95% lower in other provinces compared with Gauteng. Of all the provinces, Gauteng had the highestannual screening rates for CDL, breast cancer, prostate cancer and HIV (p < 0.001), while the Western Cape had the highest rate for cervical cancer (p < 0.001).

CONCLUSION

There is much variation in preventive care utilisation across the provinces within this health-insured population. Provinces with more abundant healthcare resources have higher screening rates. Further research is required to understand the reasons for the variation, given equal payment access.

摘要

背景

无症状疾病筛查可以降低所有人群的发病和死亡负担。医疗保健质量在地理上存在广泛的差异。关于南非全国的筛查率以及这些率在各省之间的差异,相关数据很少。

目的

在南非的所有 9 个省份中,为单一保险公司的私人保险人群检查生活方式相关慢性病(CDL)、艾滋病毒和癌症的筛查率,并确定各省之间是否存在差异。

方法

以 2011 年每个省份符合条件的成员接受筛查测试的比例计算筛查率。比较高登省和其他 8 个省之间的平均筛查率。

结果

全国 CDL、HIV 和癌症的筛查率分别为 20.5%、8.2%和 31.9%。尽管保险覆盖范围相似,但与高登省相比,其他省份的筛查率低 0.3%至 0.95%不等。在所有省份中,高登省的 CDL、乳腺癌、前列腺癌和 HIV 的年度筛查率最高(p<0.001),而西开普省的宫颈癌筛查率最高(p<0.001)。

结论

在这个有医疗保险的人群中,各省之间的预防保健利用率存在很大差异。医疗资源丰富的省份的筛查率较高。需要进一步研究,了解在同等支付准入的情况下,这种差异的原因。